These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37026876)

  • 21. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
    Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
    J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dupilumab and alopecia: A Janus effect.
    Patruno C; Napolitano M; Ferrillo M; Fabbrocini G
    Dermatol Ther; 2019 Sep; 32(5):e13023. PubMed ID: 31306557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alopecia Areata Related Paradoxical Reactions in Patients on Dupilumab Therapy: A Systematic Review.
    Sachdeva M; Witol A; Mufti A; Maliyar K; Yeung J
    J Cutan Med Surg; 2021; 25(4):451-452. PubMed ID: 33586473
    [No Abstract]   [Full Text] [Related]  

  • 24. Alopecia areata development in atopic dermatitis patients treated with dupilumab.
    Ständer S; Trense Y; Thaçi D; Ludwig RJ
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e612-e613. PubMed ID: 32311803
    [No Abstract]   [Full Text] [Related]  

  • 25. Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis.
    Barbarin C; Hosteing S; Nosbaum A; Allouchery M; Celerier P
    Eur J Dermatol; 2019 Oct; 29(5):542-543. PubMed ID: 31789276
    [No Abstract]   [Full Text] [Related]  

  • 26. Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association.
    Shamriz O; Yahia SH; Ramot Y; Agmon-Levin N; Tal Y
    Lupus; 2020 Apr; 29(4):426-430. PubMed ID: 31924144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.
    Romagnuolo M; Barbareschi M; Tavecchio S; Angileri L; Ferrucci SM
    Skin Appendage Disord; 2022 Jan; 8(1):38-41. PubMed ID: 35118128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].
    Aszodi N; Pumnea T; Wollenberg A
    Dtsch Med Wochenschr; 2019 May; 144(9):602-605. PubMed ID: 31026869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of Superficial Cryotherapy for the Treatment of Alopecia Areata.
    Kaiser M; Issa N; Yaghi M; Jimenez JJ; Issa NT
    J Drugs Dermatol; 2023 Aug; 22(8):802-809. PubMed ID: 37556514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
    Renert-Yuval Y; Pavel AB; Del Duca E; Facheris P; Pagan AD; Bose S; Gómez-Arias PJ; Angelov M; Bares J; Chima M; Estrada YD; Garcet S; Lebwohl MG; Krueger JG; Guttman-Yassky E
    Allergy; 2023 Apr; 78(4):1047-1059. PubMed ID: 36271804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.
    Cai L; Wei Y; Zhao M; Zhuo J; Tao X; Lin M
    Front Med (Lausanne); 2023; 10():1253795. PubMed ID: 37877023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Br J Dermatol; 2020 Oct; 183(4):702-709. PubMed ID: 31970750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.
    Kageyama R; Ito T; Hanai S; Morishita N; Nakazawa S; Fujiyama T; Honda T; Tokura Y
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and Emerging Therapies for Alopecia Areata.
    Pourang A; Mesinkovska NA
    Drugs; 2020 May; 80(7):635-646. PubMed ID: 32323220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dupilumab-induced psoriasis and alopecia areata: Case report and review of the literature.
    Beaziz J; Bouaziz JD; Jachiet M; Fite C; Lons-Danic D
    Ann Dermatol Venereol; 2021 Sep; 148(3):198-201. PubMed ID: 34175141
    [No Abstract]   [Full Text] [Related]  

  • 36. Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report.
    Yan X; Tayier M; Cheang ST; Liao Z; Dong Y; Yang Y; Ye Y; Zhang X
    Ther Adv Chronic Dis; 2023; 14():20406223231191049. PubMed ID: 37546700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population.
    Husein-ElAhmed H; Abdulla N; Al-Obaidli A; Ali-Alam M; Steinhoff M
    Dermatol Ther; 2022 Dec; 35(12):e15871. PubMed ID: 36177791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of atopic dermatitis-associated dupilumab-resistant alopecia totalis successfully treated with baricitinib.
    Seo T; Izumi K; Kawamura T; Tsujiwaki M; Ujiie H
    Dermatol Ther; 2022 Dec; 35(12):e15953. PubMed ID: 36269309
    [No Abstract]   [Full Text] [Related]  

  • 39. Case of alopecia areata during dupilumab treatment for atopic dermatitis.
    Kanda N; Koto M; Hoashi T; Saeki H
    J Dermatol; 2019 Sep; 46(9):e332-e333. PubMed ID: 30942915
    [No Abstract]   [Full Text] [Related]  

  • 40. Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy.
    Perche P; Purvis C; Pichardo R
    J Drugs Dermatol; 2022 Dec; 21(12):1366-1368. PubMed ID: 36468955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.